All Clinical Trials

< Back to search

Filter

1

Filter results

Results: 1

PovorcitinibA Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

PHASE3

Sponsor:

Incyte Corporation

Location:

Quebec, Phoenix AZ, Arkansas AR, Fort Smith ARshow 39 more

Code:

NCT05620823

Conditions

Hidradenitis Suppurativa (HS)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo